This Solicitation opportunity from Department Of Health And Human Services was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Illumina MiSeq i100 System

Closed

75F40126Q22123Federal

Submission Closed05/22/2026, 02:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516

New

Federal

Laboratory reagentsThe contract pertains to the procurement of laboratory reagents for the Naval Medical Research Center under the Department of Defense. It is a solicitation issued on June 16, 2026, with a response deadline set for July 1, 2026, at 4:00 PM. The contract falls under the NAICS code 334516 and does not involve any set-aside programs. The contracting office is located in Silver Spring, Maryland. Interested parties are invited to submit their responses within the specified timeframe to support the procurement needs of laboratory reagents. The primary point of contact is Genaro Vasquez, who can be reached via email for any inquiries related to this solicitation. The contract details and additional information are accessible through the provided government website link.

Naval Medical Research Center

POSTED

DEADLINE

NOI - PCA-NHLBI-07088The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, is issuing a non-competitive combined synopsis/solicitation under solicitation number 75N98026Q00630 to procure two complete CD Leycom INCA Pressure-Volume Loop Systems along with associated accessories, disposable catheters, and platinum-level training and support. This procurement supports clinical studies conducted by the National Heart, Lung, and Blood Institute’s Laboratory of Cardiovascular Intervention under an Investigational Device Exemption. The purchase will be awarded as a firm-fixed-price order to CD Leycom BV, the sole worldwide manufacturer of this invasive conductance-catheter-based system, which holds FDA 510(k) market clearance for clinical use in human patients. Due to the unique capabilities of CD Leycom’s system and its regulatory approval status, no other vendor can provide an equivalent product, justifying the non-competitive acquisition approach. This acquisition is conducted under FAR Part 12.603 for streamlined solicitation of commercial products and services and falls below the simplified acquisition threshold. It is issued as a Notice of Intent without plans for full and open competition, referencing authorities including FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901. The applicable NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees; however, this requirement is not set aside for small businesses. The solicitation incorporates provisions effective as of March 13, 2026, per the latest Federal Acquisition Circular. The response deadline is set for June 23, 2026, with point of contact information provided for coordination.

National Institutes Of Health Olao

POSTED

DEADLINE

: Laboratory Supplies for American Embassy Tbilisi, WRAIR OfficeThe contract requires the contractor to supply all specified reagents to the Walter Reed Army Institute of Research (WRAIR) Richard Lugar Center located at 99 Kakheti Highway, Tbilisi, Georgia. This is a fixed-price contract that includes pricing for all necessary labor, materials, insurance, storage, overhead, profit, and transportation to deliver the reagents according to a defined delivery schedule to the American Embassy's WRAIR office in Tbilisi. Compensation will be made for each delivery accepted by WRAIR upon submission of a proper invoice. The solicitation, titled "Laboratory Supplies for American Embassy Tbilisi, WRAIR Office," was posted on June 16, 2026, with a response deadline of July 6, 2026. The contract falls under NAICS code 334516 and is managed by the U.S. Embassy in Tbilisi, under the Department of State. Point of contact persons are Anna Kosinska and Tamar Jashi, available via email for procurement inquiries. The place of performance is Tbilisi, Georgia, and all contract administration is coordinated through the U.S. Embassy office.

POSTED

DEADLINE

Protective Clothing Blood Penetration Resistance TesterThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is conducting a market research effort to identify small businesses capable of supplying a Protective Clothing Blood Penetration Resistance Tester. This device is intended to automate and improve the testing of level 4 medical gowns for viral penetration resistance, significantly reducing manual testing time while enhancing consistency and repeatability. The instrument must meet several technical specifications, including the ability to run four simultaneous tests, automatic timing functions, real-time pressure monitoring, and compliance with ASTM F1670 and ASTM F1671 standards. The system must be new, turn-key, and include all necessary hardware, software, manuals, installation, training, and qualification documentation. Interested firms, particularly small businesses under NAICS code 334516, are invited to submit capability statements by June 23, 2026. Responses should include detailed company information, past performance data, technical compliance evidence, warranty terms, and manufacturing origin to facilitate evaluation under Buy American requirements. The delivery location is the FDA’s Winchester Engineering and Analytical Center in Massachusetts, with delivery expected within 120 days of award. This announcement does not constitute a solicitation or binding contract but serves as an information-gathering step for potential future procurements.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

FDA-RFQ- BioProfile FLEX2 Parts and Components-Brand Name or EqualThe contract solicitation seeks quotations for supplying parts and components compatible with three Nova BioProfile FLEX 2 instruments owned by the FDA’s Center for Drug Evaluation and Research (CDER). The requirement includes parts for two main FLEX2 instruments and an additional external sampling module, each identified by specific serial numbers. The contractor must provide new, unused, and defect-free commercial parts or equivalent consumables that fully function with the instruments in their current configuration, without requiring modifications. Delivered items must maintain at least 75% to 80% of their shelf life, and those requiring special conditions such as refrigeration or flammable item handling must comply with relevant regulations. Only manufacturers or authorized resellers may submit quotes, which are due via email by June 26, 2026. The contract period covers 12 consecutive months from the award date, with performance based at the FDA facility in Silver Spring, Maryland. The procurement process is issued as a combined synopsis/solicitation under commercial item acquisition rules, with no separate solicitation document forthcoming. The solicitation emphasizes strict adherence to delivery schedules and quality standards detailed in the attached Statement of Work. Communication and submission of quotations are managed through the designated FDA point of contact.

FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 10 days

AI Contract Overview

The contract involves the acquisition of one Illumina MiSeq i100 Whole Genome Sequencing System for the FDA’s Irvine Medical Products Laboratory. This procurement is conducted as a sole-source acquisition under specific federal acquisition regulations, recognizing the Illumina MiSeq i100 as the only system that meets the government’s stringent requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The package includes not only the sequencing system but also necessary components, software, delivery, installation, training, and manufacturer warranty support to ensure full operational capability. The solicitation was issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with a solicitation number 75F40126Q22123, posted on May 15, 2026. Responses were due by May 22, 2026. The contracting office is located in Rockville, Maryland, and the point of contact for inquiries is Iris Johnson. This acquisition aligns with NAICS code 334516, covering analytical laboratory instrument manufacturing. The procurement aims to support FDA’s genomic sequencing capabilities essential for its regulatory and research missions.

General Info

Sole-source purchase of Illumina MiSeq i100 system with training and warranty for FDA genomic sequencing.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Set-Aside

NONE

Documents

(3)

RFQ 75F40126Q22123 Whole Genome Sequencing Instrument for IRVLMP

PDF•rfq

Justification for Other Than Full and Open Competition for Illumina MiSeq i100 System

PDF•justification-and-authorization

SOW for Whole Genome Sequencing Instrument Purchase OC-2026-132529

PDF•sow

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 15

Solicitation

Response DeadlineMay 22

Deadline has passed

Submission Closed

05/22/2026, 02:30:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs

Contacts1 person available

OfficeRockville, MD, 20852, USA

Organization / Agency

Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Office AddressRockville, MD, 20852, USA

Contacts

Iris Johnson

contact@example.gov

+1 (555) 000-0000

Full Description

This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government’s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.